Chivukula Pad 4
4 · Arcturus Therapeutics Holdings Inc. · Filed Mar 27, 2024
Insider Transaction Report
Form 4
Chivukula Pad
Chief Scientific Officer & COO
Transactions
- Sale
Common Stock
2024-03-25$35.02/sh−17,435$610,574→ 473,448 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Reflects the weighted average price of 17,435 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on March 25, 2024, with sale prices ranging from $35.00 to $35.045 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.